Cancer Genome Atlas project yields possible breakthrough

07/19/2012 | New York Times (tiered subscription model), The

More than 200 researchers studying 224 tumors may have found a genetic vulnerability in colon cancer that could lead to targeted treatments, according to a paper published in the journal Nature. Scientists plan to test drugs already approved for other cancers that share the genetic aberration. The research is part of the Cancer Genome Atlas project, funded by the National Cancer Institute and the National Human Genome Research Institute.

View Full Article in:

New York Times (tiered subscription model), The

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
Minneapolis, MN
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Senior Paralegal - Research & Development, and Medical
Boehringer Ingelheim
Junior to Mid-Level FDA Associate
Morgan Lewis
Washington, DC
Senior Counsel – Regulatory Affairs
RAI Services Company
Winston-Salem, NC